SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-22-027464
Filing Date
2022-11-15
Accepted
2022-11-15 16:39:38
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 acrx20221104_s3.htm S-3 257266
2 EXHIBIT 5.1 ex_446538.htm EX-5.1 10229
3 EXHIBIT 23.1 ex_446536.htm EX-23.1 2387
4 EXHIBIT 23.2 ex_446537.htm EX-23.2 2386
5 EXHIBIT FILING FEES ex_442697.htm EX-FILING FEES 15449
6 a02.jpg GRAPHIC 2540
7 image01.jpg GRAPHIC 6008
  Complete submission text file 0001437749-22-027464.txt   300708
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268396 | Film No.: 221391704
SIC: 2834 Pharmaceutical Preparations